Podcasts
Listen to the latest hemonc news from international experts
The importance of early interception and intervention in myeloma
Multiple myeloma is a heterogenous and complex disease, with many experts agreeing that screening for precursor conditions can improve patient outcomes. With several new technologies emerging and an increased understanding of precursor conditions, it is evident that early intervention and interception are important steps in finding a cure for this disease.
In this exclusive podcast, Irene Ghobrial, MD, of Dana-Farber Cancer Institute, Boston, MA, discusses the importance of early interception in multiple myeloma and how screening and risk stratification can help with finding a cure.
Date: 7th June 2022
